683 Capital Management’s Eli Lilly LLY Stock Holding History

683 Capital Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$13.8M	Buy	+15,000	New	+$15.2M	0.72%	33
2025 Q4	–	Sell	-22,750	Closed	-$21.8M	–	244
2025 Q3	$17.4M	Buy	22,750 +5,000	+28%	+$3.72M	0.91%	29
2025 Q2	$13.8M	Buy	17,750 +10,250	+137%	+$7.96M	0.91%	29
2025 Q1	$6.19M	Buy	+7,500	New	+$6.24M	0.43%	66

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

683 Capital Management's LLY Position: Q1 2026 in Review

683 Capital Management opened a new position in Eli Lilly (LLY) in Q1 2026: 15,000 shares worth $13.8M. The stake represents 0.72% of the portfolio and ranks #33 among its holdings. This is a return to the name: 683 Capital Management previously reported a position in LLY as recently as Q3 2025.

683 Capital Management first reported a position in LLY in Q1 2025 and has held it in 4 quarters since. The position peaked at $17.4M in Q3 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

683 Capital Management held 15,000 shares of Eli Lilly worth $13.8M as of Q1 2026.
Eli Lilly was a new 683 Capital Management position in Q1 2026.
Eli Lilly made up 0.72% of 683 Capital Management's portfolio in Q1 2026, its #33 holding.
683 Capital Management first reported a position in Eli Lilly in Q1 2025 and has held it in 4 quarters since.
683 Capital Management's Eli Lilly position peaked at $17.4M in Q3 2025.
4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on 683 Capital Management's 13F filing for Q1 2026, filed 15 May 2026.